156 related articles for article (PubMed ID: 2858743)
1. Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.
Harinasuta T; Bunnag D; Lasserre R; Leimer R; Vinijanont S
Lancet; 1985 Apr; 1(8434):885-8. PubMed ID: 2858743
[TBL] [Abstract][Full Text] [Related]
2. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
Ellis-Pegler RB; Beeching NJ; Eales M; Fraser AG; Wells AU
Aust N Z J Med; 1988 Aug; 18(5):733-4. PubMed ID: 3072955
[No Abstract] [Full Text] [Related]
3. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ
Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709
[TBL] [Abstract][Full Text] [Related]
4. Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria.
Li GQ; Arnold K; Guo XB; Jian HX; Fu LC
Lancet; 1984 Dec; 2(8416):1360-1. PubMed ID: 6150365
[TBL] [Abstract][Full Text] [Related]
5. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
Botero D; Restrepo M; Montoya A
Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
[TBL] [Abstract][Full Text] [Related]
6. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
[TBL] [Abstract][Full Text] [Related]
7. Double-blind studies with mefloquine alone and in combination with sulfadoxine-pyrimethamine in 120 adults and 120 children with falciparum malaria in Vietnam.
Trinh KA; Nguyen VK; Arnold K; Vo VC; Nguyen NB; Kim T; Ladinsky J
Trans R Soc Trop Med Hyg; 1990; 84(1):50-3. PubMed ID: 2189246
[TBL] [Abstract][Full Text] [Related]
8. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
[TBL] [Abstract][Full Text] [Related]
9. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.
Ekue JM; Simooya OO; Sheth UK; Wernsdorfer WH; Njelesani EK
Bull World Health Organ; 1985; 63(2):339-43. PubMed ID: 3893778
[TBL] [Abstract][Full Text] [Related]
10. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
[TBL] [Abstract][Full Text] [Related]
11. Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine.
Doberstyn EB; Phintuyothin P; Noeypatimanondh S; Teerakiartkamjorn C
Bull World Health Organ; 1979; 57(2):275-9. PubMed ID: 373903
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of a low-dose mefloquine-sulfadoxine-pyrimethamine combination compared with chloroquine in the treatment of acute malaria infection in a population with multiple drug-resistant Plasmodium falciparum.
Ezedinachi EN; Ekanem OJ; Chukwuani CM; Meremikwu MM; Ojar EA; Alaribe AA; Umotong AB; Haller L
Am J Trop Med Hyg; 1999 Jul; 61(1):114-9. PubMed ID: 10432067
[TBL] [Abstract][Full Text] [Related]
13. Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis.
Win K; Thwe Y; Lwin TT; Win K
Lancet; 1985 Sep; 2(8457):694-5. PubMed ID: 2863679
[No Abstract] [Full Text] [Related]
14. Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.
Karbwang J; Looareesuwan S; Phillips RE; Wattanagoon Y; Molyneux ME; Nagachinta B; Back DJ; Warrell DA
Br J Clin Pharmacol; 1987 Apr; 23(4):477-81. PubMed ID: 3555581
[TBL] [Abstract][Full Text] [Related]
15. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
[TBL] [Abstract][Full Text] [Related]
16. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
[TBL] [Abstract][Full Text] [Related]
17. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
de Souza JM; Sheth UK; de Oliveira RM; Roulet H; de Souza SD
Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum resistant to mefloquine plus sulfadoxine/pyrimethamine.
Heizmann P; Fernex M; Leimer R; Reber-Liske R; Stohler H
Lancet; 1986 Feb; 1(8477):377. PubMed ID: 2868309
[No Abstract] [Full Text] [Related]
19. RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
Hoffman SL; Rustama D; Dimpudus AJ; Punjabi NH; Campbell JR; Oetomo HS; Marwoto HA; Harun S; Sukri N; Heizmann P
Lancet; 1985 Nov; 2(8463):1039-40. PubMed ID: 2865518
[TBL] [Abstract][Full Text] [Related]
20. Chemosuppression of malaria by the triple combination mefloquine/sulfadoxine/pyrimethamine: a field trial in an endemic area in Malaysia.
Navaratnam V; Mohamad M; Hussain S; Kumar A; Jamaludin A; Sulaiman I; Mahsufi S; Selliah K
Trans R Soc Trop Med Hyg; 1989; 83(6):755-9. PubMed ID: 2694509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
